UBS Group’s Octave Specialty Group OSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $919K | Sell |
147,197
-117,083
| -44% | -$610K | ﹤0.01% | 5807 |
|
|
2026
Q1 | $1.23M | Buy |
264,280
+110,416
| +72% | +$632K | ﹤0.01% | 5387 |
|
|
2025
Q4 | $1.2M | Sell |
153,864
-125,625
| -45% | -$1.07M | ﹤0.01% | 5422 |
|
|
2025
Q3 | $2.33M | Sell |
279,489
-80,776
| -22% | -$682K | ﹤0.01% | 4808 |
|
|
2025
Q2 | $2.56M | Buy |
360,265
+218,334
| +154% | +$1.63M | ﹤0.01% | 4561 |
|
|
2025
Q1 | $1.24M | Buy |
141,931
+52,403
| +59% | +$552K | ﹤0.01% | 5089 |
|
|
2024
Q4 | $1.13M | Buy |
89,528
+70,333
| +366% | +$848K | ﹤0.01% | 5207 |
|
|
2024
Q3 | $215K | Buy |
19,195
+8,216
| +75% | +$96.1K | ﹤0.01% | 5819 |
|
|
2024
Q2 | $141K | Sell |
10,979
-23,632
| -68% | -$360K | ﹤0.01% | 5921 |
|
|
2024
Q1 | $541K | Buy |
34,611
+6,407
| +23% | +$101K | ﹤0.01% | 5137 |
|
|
2023
Q4 | $465K | Buy |
28,204
+12,822
| +83% | +$178K | ﹤0.01% | 5168 |
|
|
2023
Q3 | $186K | Sell |
15,382
-22,542
| -59% | -$303K | ﹤0.01% | 5412 |
|
|
2023
Q2 | $540K | Sell |
37,924
-801,344
| -95% | -$11.7M | ﹤0.01% | 4755 |
|
|
2023
Q1 | $13M | Buy |
839,268
+451,498
| +116% | +$7.31M | ﹤0.01% | 1703 |
|
|
2022
Q4 | $6.76M | Buy |
387,770
+376,179
| +3,245% | +$5.59M | ﹤0.01% | 2220 |
|
|
2022
Q3 | $148K | Buy |
11,591
+2,591
| +29% | +$34.5K | ﹤0.01% | 5364 |
|
|
2022
Q2 | $102K | Sell |
9,000
-542,993
| -98% | -$5.16M | ﹤0.01% | 5416 |
|
|
2022
Q1 | $5.74M | Buy |
551,993
+541,367
| +5,095% | +$7.34M | ﹤0.01% | 2405 |
|
|
2021
Q4 | $170K | Sell |
10,626
-319
| -3% | -$5.01K | ﹤0.01% | 5836 |
|
|
2021
Q3 | $157K | Sell |
10,945
-59,558
| -84% | -$850K | ﹤0.01% | 5507 |
|
|
2021
Q2 | $1.1M | Sell |
70,503
-19,487
| -22% | -$313K | ﹤0.01% | 4098 |
|
|
2021
Q1 | $1.51M | Sell |
89,990
-6,115
| -6% | -$99.9K | ﹤0.01% | 3846 |
|
|
2020
Q4 | $1.48M | Buy |
96,105
+9,781
| +11% | +$144K | ﹤0.01% | 3675 |
|
|
2020
Q3 | $1.1M | Sell |
86,324
-474,470
| -85% | -$6.11M | ﹤0.01% | 3566 |
|
|
2020
Q2 | $8.03M | Buy |
560,794
+471,369
| +527% | +$6.89M | ﹤0.01% | 1687 |
|
|
2020
Q1 | $1.1M | Sell |
89,425
-37,132
| -29% | -$712K | ﹤0.01% | 3265 |
|
|
2019
Q4 | $2.73M | Buy |
126,557
+31,334
| +33% | +$643K | ﹤0.01% | 3225 |
|
|
2019
Q3 | $1.86M | Buy |
95,223
+28,287
| +42% | +$520K | ﹤0.01% | 3354 |
|
|
2019
Q2 | $1.13M | Buy |
66,936
+12,643
| +23% | +$216K | ﹤0.01% | 3657 |
|
|
2019
Q1 | $984K | Sell |
54,293
-15,090
| -22% | -$288K | ﹤0.01% | 3607 |
|
|
2018
Q4 | $1.2M | Buy |
69,383
+3,374
| +5% | +$61.9K | ﹤0.01% | 3508 |
|
|
2018
Q3 | $1.35M | Buy |
66,009
+7,829
| +13% | +$163K | ﹤0.01% | 3566 |
|
|
2018
Q2 | $1.16M | Buy |
58,180
+2,334
| +4% | +$43.1K | ﹤0.01% | 3652 |
|
|
2018
Q1 | $876K | Sell |
55,846
-3,598
| -6% | -$55.6K | ﹤0.01% | 3822 |
|
|
2017
Q4 | $949K | Sell |
59,444
-1,379
| -2% | -$21.2K | ﹤0.01% | 3830 |
|
|
2017
Q3 | $1.05M | Buy |
60,823
+5,051
| +9% | +$93.3K | ﹤0.01% | 3668 |
|
|
2017
Q2 | $968K | Buy |
55,772
+1,901
| +4% | +$33.8K | ﹤0.01% | 3640 |
|
|
2017
Q1 | $1.02M | Sell |
53,871
-23,662
| -31% | -$498K | ﹤0.01% | 3518 |
|
|
2016
Q4 | $1.75M | Buy |
77,533
+43,272
| +126% | +$945K | ﹤0.01% | 3039 |
|
|
2016
Q3 | $630K | Buy |
34,261
+9,889
| +41% | +$177K | ﹤0.01% | 3755 |
|
|
2016
Q2 | $401K | Sell |
24,372
-1,336
| -5% | -$21.4K | ﹤0.01% | 4056 |
|
|
2016
Q1 | $407K | Sell |
25,708
-1,899
| -7% | -$27.5K | ﹤0.01% | 3930 |
|
|
2015
Q4 | $388K | Buy |
27,607
+16,521
| +149% | +$254K | ﹤0.01% | 4149 |
|
|
2015
Q3 | $161K | Buy |
11,086
+825
| +8% | +$13.4K | ﹤0.01% | 4811 |
|
|
2015
Q2 | $170K | Buy |
10,261
+1,468
| +17% | +$34.7K | ﹤0.01% | 5009 |
|
|
2015
Q1 | $212K | Buy |
8,793
+3,138
| +55% | +$79.8K | ﹤0.01% | 4834 |
|
|
2014
Q4 | $139K | Buy |
+5,655
| New | +$132K | ﹤0.01% | 5360 |
|
Other funds holding OSG
WSL
PGCM
TAM
BCC
UBS Group's OSG Position: Q2 2026 in Review
UBS Group reduced its Octave Specialty Group (OSG) stake by 44% in Q2 2026, selling an estimated $610K and leaving 147,197 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #5807.
UBS Group first reported a position in OSG in Q4 2014 and has held it in 47 quarters since. The position peaked at $13M in Q1 2023. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.
- UBS Group held 147,197 shares of Octave Specialty Group worth $919K as of Q2 2026.
- UBS Group sold 117,083 Octave Specialty Group shares in Q2 2026, an estimated $610K.
- Octave Specialty Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5807 holding.
- UBS Group first reported a position in Octave Specialty Group in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Octave Specialty Group position peaked at $13M in Q1 2023.
- 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.